Zanidatamab (zani) in previously treated HER2+biliary tract cancer (BTC): Impact on patient-reported pain outcomes in the phase 2b HERIZON-BTC-01 study Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Pant, Shubham; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Philippe; Ying, Jie-Er; Bridgewater, John A.; Tejani, Mohamedtaki Abdulaziz; Chen, Emerson Yu-sheng; Wasan, Harpreet Singh; Ducreux, Michel Pierre; Ma, Jiafang; Garfin, Phillip M.; Harding, James J.

authors

Publication Date

  • January 20, 2024

webpage

published in

category

start page

  • 450

end page

  • 450

volume

  • 42

issue

  • 3_SUPPL